Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Accelerated Approval

<< Previous

Bullboard Posts

Next >>

Comment by Legit62on Nov 25, 2022 11:02am

225 Views

Post# 35128159

RE:RE:RE:Accelerated Approval

I would say the same after seeing all stock option and grants to insiders and Roger and Kristinas big buys , Mandels buys, etc we are very close and may have already applied and will be posted next news release. I say this cause it was the only way for insiders with info to get shares since they cant buy open market if they are privy to news

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China